Literature DB >> 1492755

n-3 polyunsaturated fatty acid supplementation (Pikasol) in men with moderate and severe hypertriglyceridaemia: a dose-response study.

E B Schmidt1, K Varming, N Svaneborg, J Dyerberg.   

Abstract

The effect of n-3 fatty acids in 11 men with hypertriglyceridaemia was investigated. The subjects were given daily supplements with three different doses of n-3 fatty acids for 8-week periods. The supplements given were 2, 4 and 9 g of n-3 fatty acids/day, respectively. Total cholesterol, triglycerides and the ratio of total cholesterol to HDL-cholesterol significantly decreased with all three doses in a dose-dependent way. HDL-cholesterol increased in a dose-dependent fashion, while apolipoproteins A1 and B were unaltered by the supplements apart from a small increase in apolipoprotein A1 after the lowest dose of n-3 fatty acids. The greatest effect was observed after 2 g of n-3 fatty acids/day.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1492755     DOI: 10.1159/000177731

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  3 in total

1.  n-3 PUFA esterified to glycerol or as ethyl esters reduce non-fasting plasma triacylglycerol in subjects with hypertriglyceridemia: a randomized trial.

Authors:  Anne Hedengran; Pal B Szecsi; Jørn Dyerberg; William S Harris; Steen Stender
Journal:  Lipids       Date:  2014-11-18       Impact factor: 1.880

2.  The acute effects of a single very high dose of n-3 fatty acids on plasma lipids and lipoproteins in healthy subjects.

Authors:  N Svaneborg; J M Møller; E B Schmidt; K Varming; H H Lervang; J Dyerberg
Journal:  Lipids       Date:  1994-02       Impact factor: 1.880

Review 3.  Omega-3 fatty acids. Current status in cardiovascular medicine.

Authors:  E B Schmidt; J Dyerberg
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.